标题
Evaluation of clinical benefits of treatments for Alzheimer's disease
作者
关键词
-
出版物
The Lancet Healthy Longevity
Volume 4, Issue 11, Pages e645-e651
出版商
Elsevier BV
发表日期
2023-11-02
DOI
10.1016/s2666-7568(23)00193-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Expectations and clinical meaningfulness of randomized controlled trials
- (2023) Ronald C. Petersen et al. Alzheimers & Dementia
- Advocating for Demonstration of Disease Modification—Have We Been Approaching Clinical Trials in Early Alzheimer Disease Incorrectly?
- (2023) Vincent Planche et al. JAMA Neurology
- Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer’s disease
- (2023) Kathy Y Liu et al. Brain Communications
- Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer’s disease
- (2022) Sheila Seleri Assunção et al. Alzheimers Research & Therapy
- Demonstration of Clinical Meaningfulness of the Integrated Alzheimer’s Disease Rating Scale (iADRS): Association Between Change in iADRS Scores and Patient and Caregiver Health Outcomes
- (2022) Alette M. Wessels et al. JOURNAL OF ALZHEIMERS DISEASE
- Clinically Relevant Changes for Cognitive Outcomes in Preclinical and Prodromal Cognitive Stages: Implications for Clinical Alzheimer Trials
- (2022) Emma Borland et al. NEUROLOGY
- Effectiveness of Treatments for People Living with Severe Dementia: A Systematic Review and Meta-Analysis of Randomised Controlled Clinical Trials
- (2022) Elena Profyri et al. AGEING RESEARCH REVIEWS
- How can secondary dementia prevention trials of Alzheimer's disease be clinically meaningful?
- (2022) Kathy Y. Liu et al. Alzheimers & Dementia
- Lecanemab in Early Alzheimer’s Disease
- (2022) Christopher H. van Dyck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Using a distribution-based approach and systematic review methods to derive minimum clinically important differences
- (2021) Jennifer A. Watt et al. BMC Medical Research Methodology
- Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis
- (2021) Sarah F Ackley et al. BMJ-British Medical Journal
- Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
- (2021) Bruno Dubois et al. LANCET NEUROLOGY
- Between-group minimally important change versus individual treatment responders
- (2021) Ron D. Hays et al. QUALITY OF LIFE RESEARCH
- How is the minimal clinically important difference established in health-related quality of life instruments? Review of anchors and methods
- (2020) Yosra Mouelhi et al. Health and Quality of Life Outcomes
- Clarifying the Meaning of Clinically Meaningful Benefit in Clinical Research
- (2019) Kevin P. Weinfurt JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Survival Analysis and Interpretation of Time-to-Event Data
- (2018) Patrick Schober et al. ANESTHESIA AND ANALGESIA
- Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses
- (2015) Robert Howard et al. LANCET NEUROLOGY
- Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
- (2012) Robert Howard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Should we reconsider the routine use of placebo controls in clinical research?
- (2012) Andrew L Avins et al. Trials
- Interpreting patient-reported outcome results: US FDA guidance and emerging methods
- (2011) Lori D McLeod et al. Expert Review of Pharmacoeconomics & Outcomes Research
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now